Materials
The advantage of osteotomy, says Gill, is that it “preserves your natural joint, and you can do it at earlier stages of the disease”. The benefits tend to last about eight to 10 years, so it is not a permanent solution, and because the plate can cause soft tissue irritation, in some cases patients experience pain and discomfort. Osteotomy is also, unfortunately, a trickier operation to perform than knee replacement, and can take up to two hours to carry out. “The success of osteotomy depends on how well you achieve the correction that you’ve planned,” says Gill. Some surgeons do not offer the operation, precisely because they are concerned about their ability to achieve the planned correction.
Using digital technology to create a perfectly fitting plate
What if you could devise an osteotomy procedure that had higher success rates, enabling more patients to benefit from it, so that they enjoy more years free of pain and are able to engage in physical activity? Gill and his colleagues have developed a solution designed to do just that. Their solution, known as Tailored Osteotomy for Knee Alignment (TOKA), involves scanning the patient’s knee and then designing the metal plate digitally so that it can be tailored to each individual patient. A 3D printer is then used to manufacture a perfectly fitting medical-grade titanium-alloy plate. The team at Bath has licensed the technology to an SME called Orthoscape, which obtained regulatory approval for the initial clinical trials. Once the software was developed, the high tibial osteotomy procedure using the personalised plates was performed on eight cadaver leg specimens to test how successful they were in achieving the planned correction. The study found a much greater accuracy in achieving the planned correction angle compared to that achieved using conventional plates.
The next stage was to test the plates virtually using CT scan data from 28 patients. Gill believes this was the first in silico trial in the world to demonstrate the safety of an orthopaedic device. It modelled the stresses that would be exerted on the personalised plates and demonstrated that they would be comparable in safety to the most commonly used generic plates. It was now time to test the safety of the procedure on live patients. The trial, carried out by the Rizzoli Institute in Bologna, Italy, assessed the mechanical effects of osteotomy in 25 patients. The results have not yet been published, but the pain results, says Gill, were “remarkable”. “Patients are getting significant pain relief at three months
Medical Device Developments /
www.nsmedicaldevices.com
and then are really almost back to normal at six months,” he adds.
Quick and simple to perform The surgery itself is relatively simple, requiring a very small set of instruments. This means that it can be performed quickly, which Gill believes is one of the reasons the trial has been so successful. “There’s always a bit of a learning curve, but the surgeon in Italy who has done 25 can now do it in 25 minutes,” Gill says. Some patients who have received the procedure in the UK are treated as day cases.
Gill is now in the process of launching a much bigger randomised controlled trial to compare the TOKA method with traditional osteotomy using generic plates. Known as the PASHiOn (Personalised Versus Standardised High Tibial Osteotomy) trial, it is funded by Versus Arthritis and will be carried out in collaboration with the NHS. When recruitment is complete, it will involve 88 patients in 10 centres.
“It’s much better to be able to give people joint-preserving treatment...and give them the ability to have active lives which then reduces all their other risk factors.”
If the trial is successful, then Gill would like to see the technology adopted throughout the NHS. Given the long waiting lists for knee replacements, and the benefits both to patients and the NHS of adopting a simpler surgery that can be performed at an earlier stage of the disease, the case for TOKA is difficult to argue with, Gill believes. The traditional osteotomy technique, he notes, involves “quite a steep learning curve for surgeons.” The TOKA system is different, however: “What we’ve been able to show through the trial we’ve done in Bologna is that surgeons can get to grips with this very quickly, and after a few cases they feel really comfortable with it. If we can get it more widely used, more people would have access to it. For people who were suitable, it would get them a treatment that works at a much earlier stage in their disease process compared to waiting for a knee replacement.”
Those patients, Gill believes, would have a higher quality of life than those that must live with the pain of knee arthritis. “It’s much better to be able to give people joint-preserving treatment earlier on in the disease process and give them the ability to have active lives which then reduces all their other risk factors,” he concludes. ●
93
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140
